Belden Inc.: Form 10-Q for the period ended Sep 27, 2020
Filed with the SEC on Nov 2, 2020 and accepted by EDGAR at Nov 2, 2020, 15:49 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-09-27. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-06-29 to 2020-09-27 | $475.8m | us-gaap:Revenues |
| Revenue | 9 months2020-01-01 to 2020-09-27 | $1.36bn | us-gaap:Revenues |
| Cost of revenue | 3 months2020-06-29 to 2020-09-27 | $308.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2020-01-01 to 2020-09-27 | $876.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-06-29 to 2020-09-27 | $167.6m | us-gaap:GrossProfit |
| Gross profit | 9 months2020-01-01 to 2020-09-27 | $488.0m | us-gaap:GrossProfit |
| Research and development | 3 months2020-06-29 to 2020-09-27 | $30.3m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2020-01-01 to 2020-09-27 | $81.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2020-06-29 to 2020-09-27 | $85.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2020-01-01 to 2020-09-27 | $275.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-06-29 to 2020-09-27 | $36.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-01-01 to 2020-09-27 | $83.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2020-06-29 to 2020-09-27 | $631.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2020-01-01 to 2020-09-27 | $3.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-06-29 to 2020-09-27 | $17.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-01-01 to 2020-09-27 | −$62.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-06-29 to 2020-09-27 | $0.38 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2020-01-01 to 2020-09-27 | −$1.39 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-06-29 to 2020-09-27 | $0.38 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2020-01-01 to 2020-09-27 | −$1.39 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-06-29 to 2020-09-27 | 44,709,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2020-01-01 to 2020-09-27 | 44,968,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2020-01-01 to 2020-09-27 | $38.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-01-01 to 2020-09-27 | $56.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2020-01-01 to 2020-09-27 | $6.8m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2020-09-27 | $391.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-09-27 | $1.01bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-09-27 | $3.04bn | us-gaap:Assets |
| Current liabilities | At period end2020-09-27 | $457.8m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2020-09-27 | $1.50bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2020-09-27 | $792.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000913142-20-000053. Last ingested by Listed: Oct 29, 2026, 14:50 ET. Listed shows no prices and gives no investment advice.